Kenvue (KVUE) shares skyrocketed in early trading Monday after Kleenex and Cottonelle maker Kimberly-Clark (KMB) said it's buying the Tylenol maker in a $48.7 billion deal.
Pfizer said it filed a second lawsuit against Novo Nordisk and Metsera, alleging that the Danish drugmaker's attempt to outbid Pfizer to acquire the obesity biotech is anticompetitive. The new suit escalates a heated standoff between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the blockbuster weight loss drug market.
Kimberly-Clark Corp (NYSE:KMB, ETR:KMY) announced it will acquire Kenvue (NYSE:KVUE), the maker of Tylenol and other consumer health products, in a cash and stock transaction valued at approximately $48.7 billion. Under the agreement, Kenvue shareholders will receive $3.50 per share in cash plus 0.14625 Kimberly-Clark shares for each Kenvue share, totaling $21.01 per share based on Kimberly-Clark's recent stock price.
Ryanair Holdings plc ( RYAAY ) Q2 2026 Earnings Call November 3, 2025 5:00 AM EST Company Participants Michael O'Leary - Group CEO & Executive Director Neil Sorahan - Group Chief Financial Officer Edward Wilson - Chief Executive Officer of Ryanair DAC Tracey McCann - Chief Financial Officer of Ryanair DAC Michal Kaczmarzyk - Chief Executive Officer of Buzz John Norton - Group Treasurer Thomas Fowler - Director of Sustainability & Finance Conference Call Participants Harry Gowers - JPMorgan Chase & Co, Research Division James Hollins - BNP Paribas, Research Division Jaime Rowbotham - Deutsche Bank AG, Research Division Jarrod Castle - UBS Investment Bank, Research Division Stephen Furlong - Davy, Research Division Alexander Irving - Sanford C. Bernstein & Co., LLC.
IDEXX Laboratories, Inc. ( IDXX ) Q3 2025 Earnings Call November 3, 2025 8:30 AM EST Company Participants Andrew Emerson - Executive VP, CFO & Treasurer Jay Mazelsky - President, CEO & Director Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Michael Ryskin - BofA Securities, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Christopher Schott - JPMorgan Chase & Co, Research Division Daniel Christopher Clark - Leerink Partners LLC, Research Division Brandon Vazquez - William Blair & Company L.L.C., Research Division Andrea Zayco Narvaez Alfonso - UBS Investment Bank, Research Division Keith Devas - Jefferies LLC, Research Division Presentation Operator Good morning, and welcome to the IDEXX Laboratories Third Quarter 2025 Earnings Conference Call.
Home Depot (HD) has quietly built a reputation not just as a home improvement giant, but as one of the market's most consistent wealth creators. While investors often focus on growth stories in tech or energy, the Atlanta-based retailer has been funneling extraordinary amounts of cash back to its shareholders year after year.
In a market driven by hype and momentum, Accenture (ACN) stands out as a steady performer with solid fundamentals and a discounted valuation — proof that “boring” can still be beautiful.
Tesla (TSLA) shareholders will be voting on Tesla CEO Elon Musk's $1 trillion pay package ahead of the company's annual shareholder meeting on Thursday, Nov. 6. Sevens Report Research founder Tom Essaye tells Yahoo Finance that shareholders should "write the check" and let Musk "do his thing."
Canada is launching dispute settlement proceedings against auto manufacturer Stellantis over its decision to shift production from a Canadian plant to one in the United States, Industry Minister Melanie Joly said on Monday.
LOS ANGELES, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 30, 2023 and July 3, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before November 18, 2025.
Meta Platforms, Inc. reported Q3 FY2025 results showing revenue growth but declining EPS, driven by slowing ad growth in key markets. META's AI initiatives, including Llama LLMs and major datacenter investments, have yet to yield significant traction or profitability outside its core apps. Capital expenditures are surging, with the Hyperion datacenter joint venture reflecting strategic flexibility but also highlighting high spending versus monetization.
Boeing's stock had a tougher week after releasing their Q3 '25 financial results on Wednesday morning, October 29th, with the stock falling roughly 9-10% over the five-day period. The unexpected negative news on the call was that the 777X took a bigger quarterly charge in Q3 '25, thus causing an actual EPS loss of ($7.47) versus the estimated EPS of ($5.15). The quarterly loss for the Commercial Airline Segment was ($5.3) billion, the largest quarterly loss for Commercial since December '21's ($4.45) billion hit.
Cipher Mining Inc (NASDAQ: CIFR) on Monday announced that it has signed a 15-year lease agreement with Amazon Web Services (AWS), valued at about $5.5 billion, to provide turnkey space and power for AI workloads. Cipher Mining said under the terms of the deal it will deliver 300 megawatts (MW) of capacity in 2026, including both air and liquid cooling to the racks.
MILWAUKEE , Nov. 3, 2025 /PRNewswire/ -- The Ademi Firm is investigating Intermex (Nasdaq: IMXI) for possible breaches of fiduciary duty and other violations of law in its transaction with Western Union. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.
Tesla stock climbed more than 3% to $470.38 in early trading on Monday, placing it within 4% of its all-time high of $488.54 reached in December 2024. The rally comes even as the electric-vehicle maker's European sales showed steep declines in October.
MILWAUKEE , Nov. 3, 2025 /PRNewswire/ -- The Ademi Firm is investigating Vital Energy (NYSE: VTLE) for possible breaches of fiduciary duty and other violations of law in its transaction with Crescent Energy Company. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.
The U.S. has become the first country to export 10 million metric tonnes (mmt) of liquefied natural gas in a single month, according to preliminary data from financial firm LSEG.
LEAWOOD, Kan.--(BUSINESS WIRE)--AMC Theatres (NYSE:AMC), the largest theatrical exhibitor in the United States and in the world, today announced multiple senior-level promotions across the Company. Edwin (Eddie) Gladbach has been named Senior Vice President, General Counsel & Secretary, after serving as Interim General Counsel & Secretary since February. He will report to Adam M. Aron, Chairman and CEO, and will sit on AMC's Executive Committee. Gladbach will oversee all legal, regulato.
Meren Energy Inc (TSX:MER, OTCQX:MRNFF) announced that its common shares have begun trading on the OTCQX Best Market in the US under the ticker symbol “MRNFF.” The company said its shares will continue to trade on the Toronto Stock Exchange and Nasdaq Stockholm under the symbol “MER.
LOS ANGELES, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Quanex Building Products Corporation (“Quanex” or “the Company”) (NYSE: NX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between December 12, 2024 and September 5, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before November 18, 2025.